Krämer, Stephanie <br/><br/>
Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.  [electronic resource] 

 -  American journal of physiology. Renal physiology  Aug 2005 
 - F359-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1931-857X 
<br/><br/><label>Standard No.: </label>10.1152/ajprenal.00442.2004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Animals<br/>Blood Cell Count<br/>Blood Pressure--drug effects<br/>Body Weight--drug effects<br/>Disease Progression<br/>Drug Interactions<br/>Eating--physiology<br/>Enalapril--therapeutic use<br/>Fibronectins--metabolism<br/>Fibrosis<br/>Glomerulosclerosis, Focal Segmental--drug therapy<br/>Immunohistochemistry<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Diseases--drug therapy<br/>Kidney Function Tests<br/>Male<br/>Mycophenolic Acid--analogs & derivatives<br/>Nephrectomy<br/>Plasminogen Activator Inhibitor 1--biosynthesis<br/>Proteinuria--drug therapy<br/>Rats<br/>Rats, Wistar<br/>Thy-1 Antigens--immunology<br/>Transforming Growth Factor beta--metabolism<br/>Transforming Growth Factor beta1